Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2015

View Archived Issues

NO-donating bimatoprost shows preclinical efficacy reducing IOP

FDA designates Cidara's CD-101 IV as QIDP

Lilly and BioNTech form cancer immunotherapy collaboration

NAPs show promising sequence-independent antiviral activity

Retrophin introduces compounds for the treatment of neurodegeneration

Roche patents CYP11B2 inhibitors

Astellas to access Cyclenium's macrocycle drug discovery technologies

Roivant Sciences licenses nelotanserin from Arena Pharmaceuticals

Sumitomo Dainippon Pharma profiles progress of fourth quarter of fiscal 2014

Celprogen reveals pancreatic stem cell stimulator STEMC-7007

Data on REGN-844 for dry eye disease reported

PIM-447 shows potential for the treatment of MM

Merck & Co. discloses ROM-K channel blockers

Michael J. Fox Foundation acquires research tools from Imago

Dana-Farber, Syros Pharmaceuticals and Paraza Pharma jointly patent CDK7 inhibitors

Evofosfamide receives FDA fast track designation for pancreatic cancer

Shionogi prepares and tests ACC2 inhibitors

Astellas Pharma discloses GABA(B) positive allosteric modulators

Intravitreal CD34+ autologous bone marrow-derived cells safe in dry AMD patients

MorphoSys completes acquisition of Lanthio Pharma

FDA advisory committee recommends approval of Orkambi for cystic fibrosis

Preliminary phase I results of Ebola prime-boost vaccine regimen of MVA-BN Filo and AdVac

Takeda terminates phase III trial of alisertib in peripheral T-cell lymphoma

Fibrocell's FCX-007 receives rare pediatric disease designation from the FDA

FDA awards orphan drug designation to SemiAlloGen's approach to targeting glioblastoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...